Regular ArticleSelf-Assembly of β-Amyloid 42 Is Retarded by Small Molecular Ligands at the Stage of Structural Intermediates
References (69)
- et al.
Cryo-negative staining
Micron
(1998) - et al.
Three-dimensional structure determination by electron microscopy of two-dimensional crystals
Prog. Biophys. Mol. Biol.
(1982) - et al.
Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin
J. Struct. Biol.
(1995) - et al.
Hydrogen peroxide mediates amyloid beta protein toxicity
Cell
(1994) - et al.
Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix
Structure
(1996) - et al.
Endogenous Proteins Controlling Amyloid beta-Peptide Polymerization. Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues
J. Biol. Chem.
(1999) - et al.
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs
J. Biol. Chem.
(1992) - et al.
Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism
J. Mol. Biol.
(1985) - et al.
pH-dependent structural transitions of alzheimer amyloid peptides
Biophys. J.
(1991) - et al.
Watching amyloid fibrils grow by time-lapse atomic force microscopy
J. Mol. Biol.
(1999)
Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43)
J. Biol. Chem.
Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein
Chem. Biol.
Observation of metastable Abeta amyloid protofibrils by atomic force microscopy
Chem. Biol.
Hemin and related porphyrins inhibit beta-amyloid aggregation
FEBS Lett.
Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide
Neurodegeneration
Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: Analysis by x-ray diffraction
Biophys. J.
Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
Cell
J. Immunol. Methods
The wrapping phenomenon in air-dried and negatively stained preparations
Ultramicroscopy
In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice
J. Struct. Biol.
Controlling polymerization of beta-amyloid and prion-derived peptides with synthetic small molecule ligands
J. Biol. Chem.
Structural neurology: Are seeds at the root of neuronal degeneration?
Neuron
Structural analysis of Alzheimer's beta(1-40) amyloid: Protofilament assembly of tubular fibrils
Biophys. J.
Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain
J. Biol. Chem.
In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity
Brain Res.
Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease
J. Biol. Chem.
The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology
J. Struct. Biol.
Examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs
J. Mol. Biol.
Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate
J. Biol. Chem.
Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates
J. Biol. Chem.
Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta
J. Mol. Biol.
Molecular modeling of the Abeta1-42 peptide from Alzheimer's disease
Protein Eng.
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene
Nature
A biotechnological method provides access to aggregation competent monomeric Alzheimer's 1-42 residue amyloid peptide
Biotechnology
Cited by (55)
Ro 90-7501 inhibits PP5 through a novel, TPR-dependent mechanism
2017, Biochemical and Biophysical Research CommunicationsCitation Excerpt :Ro 90-7501 might exert its inhibitory effect on PP5 by binding to the TPR domain and tightening the autoinhibited conformation of PP5. It has been reported that Ro 90-7501 efficiently retarded mature fibril formation of amyloid-β which is considered responsible for Alzheimer's disease [26]. Another research showed that Ro 90-7501 enhanced TLR/RLR agonist induced antiviral response, possibly via selective activation of p38 MAPK pathway [27].
Inhibition of amyloid fibril formation and cytotoxicity by a chemical analog of Curcumin as a stable inhibitor
2015, International Journal of Biological MacromoleculesCitation Excerpt :Classical suggested approaches to treat amyloidogenic diseases target the amyloidogenic formation of proteins (reduction), or the clearance rate of misfolded/aggregated proteins (increase); accordingly, the stability of proteins native state could be increased, or direct inhibition of the self-assembly process may be aimed [18]. Multiple studies have reported that small organic molecules containing single or multiple (hetero) aromatic residues, possess in vitro anti aggregation activity [19,20]. This inhibitory effect may be exerted through several mechanism: stopping formation of mature fibrils from monomers [19], preventing both oligomers and fibril formation [21], affecting only oligomers without effect on mature fibrils formation, or block mature fibrils while allowing oligomer formation [22].
Oligomeric intermediates in amyloid formation: Structure determination and mechanisms of toxicity
2012, Journal of Molecular BiologyCitation Excerpt :For example, certain metabolites,143 lipids,27,111 glycosaminoglycanes142 and metal ions144 can promote oligomerization or act as enhancers within the mechanism of amyloid or oligomer formation. Inhibitory factors, by contrast, hold the perspective of being therapeutically relevant,145 and recent research focused on possibilities to interfere with a particular intermediate.146 Specific polyphenols were shown to destabilize amyloid fibrils and oligomers.147,148
Design, synthesis and biological evaluation of indane-2-arylhydrazinylmethylene-1,3-diones and indol-2-aryldiazenylmethylene-3-ones as β-amyloid aggregation inhibitors
2010, European Journal of Medicinal ChemistryCitation Excerpt :Over the years small organic molecules containing single or multiple (hetero)aromatic residues very often with phenolic hydroxyls, have been extensively tested for their ability to inhibit Aβ fibrillization in vitro (Chart 1). The detected inhibitors include Congo red [9], furan [10], indole [11–13], and bis-styrylbenzene derivatives [14], stilbenes [15], curcumin [16], quercetin [17], and many other diverse synthetic and natural compounds [18–20]. Several studies have suggested that interactions between aromatic units may play an important role in many areas of chemistry and biochemistry, most notably in molecular recognition and self-assembly [21–24].
- 1
To whom correspondence should be addressed. Fax: 41-61-688 49 43. E-mail: [email protected].